We will not keep your email address; we ask for it so your friend knows the email isn't spam.

You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your ...

A drug in advanced development for myasthenia gravis also showed promise as a treatment for primary Sjögren's syndrome, a ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Ania Turska is going through 'intensive' therapy to regain her ability to walk and talk, after being placed in a medically ...

Your nervous system is a key force behind so many important bodily functions. But when your peripheral nerves—those found outside of the brain and spinal cord—are damaged, it can cause pain and ...

An Edinburgh woman is going through 'intensive' therapy to regain her ability to walk and talk, after being placed in a ...

Analysts appear optimistic for Intellia’s gene editor nex-z, which showed a greater serum TTR reduction than Alnylam’s ...

Intellia's Phase 3 trial for NTLA-2002 shows promise, but limitations warrant caution. See why we believe NTLA stock is hold ...

Experts view BridgeBio’s acoramidis—which has an FDA action date of Nov. 29—as either similar to or incrementally better than ...

We provide Severe Weather Warnings for potentially hazardous or dangerous weather that is not solely related to severe thunderstorms, tropical cyclones or bushfires. We provide Coastal Hazard Warnings ...

None of the patients had grade-III (severe) neuropathy ... that many patients with liver cirrhosis have an associated peripheral neuropathy, which is usually subclinical or mild, that is better ...